Research Article
Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell Lung Cancer: Relation to Different Hematologic Indices
Table 2
Clinicopathologic characteristics of 40 patients with NSCLC.
| Characteristics | Descriptive |
| Age () | | Median | 59.5 y | Sex (male/female) | 25/15 | Smoking | | Never smoker | 17 (42.5%) | Current smoker | 11 (27.5%) | Past smoker | 12 (30%) | ECOG-PS | | | 12 (30%) | | 13 (32.5%) | | 15 (37.5%) | Histopathology | | Squamous cell carcinoma | 12 (30%) | Adenocarcinoma | 23 (57.5%) | Large cell carcinoma | 4 (10%) | Bronchoalveolar carcinoma | 1 (2.5%) | Stage | | IIIA | 9 (22.5%) | IIIB | 14 (35%) | IV | 17 (42.5%) | Median number of chemotherapy cycles | 3 (range: 0–7) | LMR () | | MPV/PC ratio () | | Relative monocytic count | | Relative lymphocytic count | | Outcome | | Dead | 26 (65%) | Alive | 14 (35%) |
|
|
LMR: lymphocyte to monocyte ratio; MPV/PC ratio: mean platelet volume to platelet count ratio; ECOG-PS: Eastern Cooperative Oncology Group-performance status.
|